A mixed methods analysis of clinics’ perspectives on community factors influencing access to medications for opioid use disorder
The data for this study is from the Stagewise Implementation-to-Target - Medications for Addiction Treatment clinical trial registered as NCT05343793 on April 25, 2022.
Authors
- Hélène Chokron Garneau (ORCID: https://orcid.org/0000-0002-0113-0400)
- Michele Gassman (ORCID: https://orcid.org/0000-0002-2575-2976)
- Samuel Jaros (ORCID: https://orcid.org/0000-0003-4626-5293)
- James H. Ford (ORCID: https://orcid.org/0000-0003-3045-2414)
- Maryam Abdel Magid
- Mark McGovern
- Hannah Cheng
Institutions
- Northwestern University (US)
- University of Wisconsin–Madison (US)
- University of Washington Medical Center (US)
- Stanford Medicine (US)
- Stanford University (US)
Publication Details
- Journal
- Addiction Science & Clinical Practice
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1186/s13722-025-00643-1
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00